Femasys (FEMY) Non Operating Income (2020 - 2025)
Femasys (FEMY) reported Non Operating Income of -$260000.0 for Q2 2025, down 27.34% on a YoY basis from -$357845.7 in Q2 2024, and up 40.97% quarter-over-quarter from -$440420.0 in Q1 2025.
Femasys (FEMY) Non Operating Income (2020 - 2025) Analysis & Trends
Femasys has reported Non Operating Income for 6 years, with the latest figure at -$260000.0 in Q2 2025.
- For the quarter ending Q2 2025, Non Operating Income fell 27.34% year-over-year to -$260000.0; the trailing twelve-month figure through Jun 2025 stood at -$359379.0 (down 68.5% YoY), and the FY2025 full-year result was -$482562.0, changed N/A from the prior year.
- Non Operating Income for Q2 2025 stood at -$260000.0, up from -$440420.0 in the prior quarter.
- The five-year high for Non Operating Income was $818016.0 in Q2 2021, with the low at -$440420.0 in Q1 2025.
- Historically, Non Operating Income has averaged $34367.4 across 5 years, with a median of $25862.0 in 2022.
- Annual changes were most pronounced in 2021 — Non Operating Income surged 45095.38% — and 2024, when it slumped 580.93%.
- Femasys' Non Operating Income stood at -$3117.0 in 2021, then soared by 3708.15% to $112466.0 in 2022, then tumbled by 61.41% to $43399.0 in 2023, then surged by 1352.34% to $630303.0 in 2024, then slumped by 141.25% to -$260000.0 in 2025.
- The last three Non Operating Income figures came in at -$260000.0 (Q2 2025), -$440420.0 (Q1 2025), and $630303.0 (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 85.10 Mn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 86.00 Mn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | -131.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | -1.37 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | -200,000.00 |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | -4.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 3.50 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 3.02 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | -6.00 Mn |
| 10 | Femasys | 254.59 Mn | 249.20 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -260,000.00 |
| Mar 31, 2025 | -440,420.00 |
| Dec 31, 2024 | 630,303.00 |
| Sep 30, 2024 | -289,262.00 |
| Jun 30, 2024 | -204,173.00 |
| Mar 31, 2024 | -136,868.00 |
| Dec 31, 2023 | 43,399.00 |
| Sep 30, 2023 | 84,359.00 |
| Jun 30, 2023 | 42,454.00 |
| Mar 31, 2023 | 95,417.00 |
| Dec 31, 2022 | 112,466.00 |
| Sep 30, 2022 | 74,346.00 |
| Jun 30, 2022 | 25,862.00 |
| Mar 31, 2022 | -280.00 |
| Dec 31, 2021 | -3,117.00 |
| Sep 30, 2021 | -8,256.00 |
| Jun 30, 2021 | 818,016.00 |
| Dec 31, 2020 | 6,746.00 |
| Sep 30, 2020 | -3,418.00 |
| Jun 30, 2020 | -1,818.00 |